Clinical trial
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast…
NCT00378638 · Chap, Linnea I., M.D., Other · Unknown status
Key facts
| NCT number | NCT00378638 |
|---|---|
| Title | Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study |
| Official title | Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymp Node Positive Breast Cancer: A Pilot Study |
| Lead sponsor | Chap, Linnea I., M.D., Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | bevacizumab combined with dose dense chemotherapy |
| Enrollment | 30 |
| Start date | Jun 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Sep 20, 2006 |
| Last update posted | Oct 24, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: